LONDON — Wearing eyelash extensions is a significant risk factor for Demodex infestation, according to a study conducted at National Pirogov Memorial Medical University in Vinnytsia, Ukraine.
“Lash extensions have become a routine cosmetic procedure, particularly among young women, creating a new potential environmental stressor for the eyelid margin and ocular surface,” Tetiana Zhmud, MD, said at the European Society of Cataract and Refractive Surgeons meeting.
Zhmud highlighted studies demonstrating that eyelash extensions can disrupt ocular surface homeostasis, causing corneal epithelial

Most prostate cancer intervention studies occur in high-income countries, and no trials are conducted in countries considered low-income based on World Bank Ranking.
Data from 1,400 investigations initiated between 2019 and 2024 showed a country’s wealth had a significant association with trial availability, but not prostate cancer incidence or mortality.
“We have to be mindful of the patient in front of us, to see if the data and the evidence that we are applying to them is actually applicable, especially if you are working in settings and with patient populations that are underrepresented in

Atogepant, a calcitonin gene-related peptide receptor agonist, showed significant reductions in migraine days related to menstrual period, according to topline results from AbbVie.
The findings from the Phase 3 LUNA study offer early evidence of how calcitonin gene-related peptides (CGRP) can play a role in treating menstrual migraine specifically, said Karen Carr, PhD, scientific director, migraine, with AbbVie. No treatment options are currently approved for that specific patient population.
“These attacks can be more severe, last longer and be harder to treat than attacks at other times in

Lawmakers questioned Nicole Saphier, MD, on abortion bans, vaccines and other preventive health issues during Wednesday’s hearing to be the next surgeon general.
In May, President Donald J. Trump announced Saphier would replace Casey Means, MD, as his nominee for the position after months of a stalled process.
In a post to Truth Social, Trump described Saphier, a radiologist and director of breast imaging at Memorial Sloan Kettering Cancer Center Monmouth, as “a STAR physician.”
“She is also an INCREDIBLE COMMUNICATOR, who makes complicated health issues more easily understood by all Americans,”

Editor’s note: This is part three of a Healio Dermatology back-to-school skin series, where experts discuss common adolescent skin conditions, treatments and trends. Read part one here. Read part two here.
Sunscreen may not top the back-to-school shopping list for some parents as children return to classrooms, but dermatologists caution that photoprotective measures should be a year-round practice to protect skin and prevent skin cancer.
Healio spoke with Dawn Marie R. Davis, MD, professor of dermatology and pediatrics at Mayo Clinic Rochester in Rochester, Minnesota and a Healio Dermatology

Hubble recently announced the appointment of Jeff Berger as CEO as well as the release of the new Classic 2.0 daily contact lens, according to two press releases from the company.
“Over the past decade, Hubble has built a brand that millions of consumers know, so there is already a strong foundation — and an enormous opportunity ahead,” Berger told Healio.
In his new role, Berger, who previously held leadership roles at companies focused on career development and networking, will drive innovation by shaping Hubble’s long-term direction and leading its operations and

The FDA has approved finerenone as a therapy to lower urinary albumin-to-creatinine ratio among adults with chronic kidney disease associated with type 1 diabetes, Bayer announced.
Finerenone (Kerendia, Bayer), a once-daily oral nonsteroidal mineralocorticoid receptor antagonist, received approval for adults with CKD associated with type 1 diabetes based on data from the phase 3 FINE-ONE trial. As Healio previously reported from ASN Kidney Week, adults who received 10 mg to 20 mg of once-daily finerenone had a 34% decrease in urinary albumin-to-creatine ratio from baseline to 6 months compared

Two new oral “carbapenems” — sulopenem (technically a thiopenem) and tebipenem — have recently been approved by the FDA for the treatment of UTIs, possibly heralding a new era in antimicrobial therapy for multidrug-resistant UTIs.
Sulopenem (Orlynvah, Iterum Therapeutics) and tebipenem (Utebzi, GSK and Spero Therapeutics) have broad spectra similar to ertapenem, exhibiting potent activity against Enterobacterales — including extended-spectrum beta-lactamase (ESBL)- and ampC-producing organisms — limited activity against Enterococcus species, and no activity

The CDC announced it is investigating reports of illnesses across four states associated with glutathione injections.
More than 25 illnesses have been identified. They are linked to injections containing dietary supplement grade glutathione, not pharmaceutical grade glutathione.
Dietary supplement grade glutathione “is not an appropriate ingredient to make injectable drugs,” according to the FDA.
Glutathione is a naturally produced antioxidant. There are no FDA-approved glutathione products, but compounded formulations have been used for skin care and wellness. It also has been evaluated for

Welp, here we are again. It is September, and that means we are talking inflammation. More specifically, fighting inflammation in dry eye disease.
This space has been a literal godsend for eyeball pundits. We have a plethora of colorful characters to write about. Think late-night talk show hosts and literally every U.S. president since Nixon.
Unlike every year since I started sharing my nonsense, this year there has not been much going on at the Dry Eye Saloon. I thought I might go back to the basics of inflammation, how it affects the ocular surface, and the “whats” and “whys” of how we treat